<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 14, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02324855</url>
  </required_header>
  <id_info>
    <org_study_id>Exacerb_BQnoFQ</org_study_id>
    <nct_id>NCT02324855</nct_id>
  </id_info>
  <brief_title>Long-term Airway Clearance Therapy in Non-cystic Fibrosis Bronchiectasis</brief_title>
  <official_title>Long Term Airway Clearance Therapy in Non Cystic Fibrosis Bronchiectasis: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad San Jorge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad San Jorge</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim is to analyze whether the routine use of chest physiotherapy in non cystic&#xD;
      fibrosis bronchiectasis (NCFB) improves the cough severity and the quality of life in this&#xD;
      population. In addition, the secondary end-points include incidences of exacerbations,&#xD;
      changes in lung function, exercise capacity, airways inflammation, sputum analysis and&#xD;
      eventual adverse events.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present project will be a single-blind , randomized, controlled trial of 12-month daily&#xD;
      performing chest physiotherapy compared with usual care, followed by a 3-month&#xD;
      intervention-free in non-cystic fibrosis bronchiectasis.&#xD;
&#xD;
      Intervention group will perform daily autonomous airway clearance techniques (positive&#xD;
      expiratory pressure technique through Acapella device and autogenic drainage technique).&#xD;
      Patients will receive professional sessions once a month.&#xD;
&#xD;
      Control group will receive their usual care and educational sessions about their disease.&#xD;
      Physiotherapist will call them once a month.&#xD;
&#xD;
      During the study period the patients' pharmacological treatment remained unchanged&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">June 2020</completion_date>
  <primary_completion_date type="Actual">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cough severity (Auto-administered questionnaire: Leicester Cough Questionnaire)</measure>
    <time_frame>1 year</time_frame>
    <description>Auto-administered questionnaire: Leicester Cough Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (Quality of life-Bronchiectasis questionnaire)</measure>
    <time_frame>1 year</time_frame>
    <description>Auto-administered questionaire: Quality of Life- Bronchiectasis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exacerbation frequency</measure>
    <time_frame>1 year</time_frame>
    <description>Number of exacerbation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity (Incremental field test: shuttle test)</measure>
    <time_frame>1 year</time_frame>
    <description>Incremental field test: shuttle test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>1 year</time_frame>
    <description>Simple spirometry: Forced expiratory volume at 1 second, Forced vital capacity, Forced expiratory flow 25-75</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway inflammation as assessed by spontaneous sputum analysis</measure>
    <time_frame>1 year</time_frame>
    <description>Inflammatory sputum markers: Myeloperoxidase (MPO) and Cytokines (IL-8)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Bronchiectasis</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will receive the usual medical care in accordance with Spanish non cystic fibrosis bronchiectasis guidelines. In addition they will receive educational sessions about their disease and their pharmacology treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chest physiotherapy plus usual care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will introduce chest physiotherapy as part of their daily treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chest physiotherapy plus usual care</intervention_name>
    <description>Subjects will perform daily chest physiotherapy during at least 30 minutes. Patients will perform a slow expiratory airway clearance technique combined with positive expiratory pressure device (Acapella device, Murray et al.) Each patient will receive 12 supervised professional sessions (once a month).</description>
    <arm_group_label>Chest physiotherapy plus usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic sputum production during at least 3 months previous enrolment&#xD;
&#xD;
          -  At least two confirmed exacerbations during the last year&#xD;
&#xD;
          -  Patients able to understand how to perform the airway clearance techniques&#xD;
&#xD;
          -  Clinically stable at time of study entry (defined as no requirement for antibiotics or&#xD;
             change in respiratory medication in the preceding 4 wk)&#xD;
&#xD;
          -  To be able to provide written, informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cystic Fibrosis&#xD;
&#xD;
          -  Carry out regular chest physiotherapy.&#xD;
&#xD;
          -  Active haemoptysis during the previous month or recurrent hemoptysis during the last&#xD;
             year (more than 4 episodes)&#xD;
&#xD;
          -  Waiting a pulmonary transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatriz Herrero, Msc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad San Jorge</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad San Jorge</name>
      <address>
        <city>Zaragoza</city>
        <zip>50830</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Murray MP, Pentland JL, Hill AT. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009 Nov;34(5):1086-92. doi: 10.1183/09031936.00055509. Epub 2009 Jun 18.</citation>
    <PMID>19541717</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 1, 2014</study_first_submitted>
  <study_first_submitted_qc>December 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2014</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Autogenic drainage</keyword>
  <keyword>Positive expiratory pressure</keyword>
  <keyword>Airway clearance technique</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Exacerbations</keyword>
  <keyword>Chest physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

